These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 26143491)
1. AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer. Jhaveri TZ; Woo J; Shang X; Park BH; Gabrielson E Oncotarget; 2015 Jun; 6(17):14754-65. PubMed ID: 26143491 [TBL] [Abstract][Full Text] [Related]
2. Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1. Fodor T; Szántó M; Abdul-Rahman O; Nagy L; Dér Á; Kiss B; Bai P PLoS One; 2016; 11(2):e0150232. PubMed ID: 26919657 [TBL] [Abstract][Full Text] [Related]
3. PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation. Liu S; Tang Y; Yan M; Jiang W Invest New Drugs; 2018 Oct; 36(5):763-772. PubMed ID: 29504069 [TBL] [Abstract][Full Text] [Related]
4. 5'-AMP-activated protein kinase (AMPK) regulates progesterone receptor transcriptional activity in breast cancer cells. Wu L; Huang XJ; Yang CH; Deng SS; Qian M; Zang Y; Li J Biochem Biophys Res Commun; 2011 Dec; 416(1-2):172-7. PubMed ID: 22093824 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR). Zhuge J Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182 [TBL] [Abstract][Full Text] [Related]
6. AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway. Chang MY; Ho FM; Wang JS; Kang HC; Chang Y; Ye ZX; Lin WW Biochem Pharmacol; 2010 Oct; 80(8):1210-20. PubMed ID: 20615388 [TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo. Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413 [TBL] [Abstract][Full Text] [Related]
8. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition. Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619 [TBL] [Abstract][Full Text] [Related]
9. Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells. Zheng QY; Jin FS; Yao C; Zhang T; Zhang GH; Ai X Biochem Biophys Res Commun; 2012 Mar; 419(4):741-7. PubMed ID: 22387548 [TBL] [Abstract][Full Text] [Related]
10. AMPK activators suppress breast cancer cell growth by inhibiting DVL3-facilitated Wnt/β-catenin signaling pathway activity. Zou YF; Xie CW; Yang SX; Xiong JP Mol Med Rep; 2017 Feb; 15(2):899-907. PubMed ID: 28035400 [TBL] [Abstract][Full Text] [Related]
11. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells. Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462 [TBL] [Abstract][Full Text] [Related]
12. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells. Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047 [TBL] [Abstract][Full Text] [Related]
13. Chronic high cytosolic calcium decreases AICAR-induced AMPK activity via calcium/calmodulin activated protein kinase II signaling cascade. Park S; Scheffler TL; Gerrard DE Cell Calcium; 2011 Jul; 50(1):73-83. PubMed ID: 21641034 [TBL] [Abstract][Full Text] [Related]
14. Kinase-independent transcriptional co-activation of peroxisome proliferator-activated receptor alpha by AMP-activated protein kinase. Bronner M; Hertz R; Bar-Tana J Biochem J; 2004 Dec; 384(Pt 2):295-305. PubMed ID: 15312046 [TBL] [Abstract][Full Text] [Related]
15. Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells. Chen MB; Zhang Y; Wei MX; Shen W; Wu XY; Yao C; Lu PH Cell Signal; 2013 Oct; 25(10):1993-2002. PubMed ID: 23712032 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 ('Iressa') is independent of EGFR expression level. Campiglio M; Locatelli A; Olgiati C; Normanno N; Somenzi G; Viganò L; Fumagalli M; Ménard S; Gianni L J Cell Physiol; 2004 Feb; 198(2):259-68. PubMed ID: 14603528 [TBL] [Abstract][Full Text] [Related]
17. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination. Balz LM; Bartkowiak K; Andreas A; Pantel K; Niggemann B; Zänker KS; Brandt BH; Dittmar T J Pathol; 2012 Jun; 227(2):234-44. PubMed ID: 22262199 [TBL] [Abstract][Full Text] [Related]
18. AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3). Nerstedt A; Johansson A; Andersson CX; Cansby E; Smith U; Mahlapuu M Diabetologia; 2010 Nov; 53(11):2406-16. PubMed ID: 20652679 [TBL] [Abstract][Full Text] [Related]
19. EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance. Dua R; Zhang J; Nhonthachit P; Penuel E; Petropoulos C; Parry G Breast Cancer Res Treat; 2010 Aug; 122(3):685-97. PubMed ID: 19859802 [TBL] [Abstract][Full Text] [Related]
20. AICAR-induced activation of AMPK negatively regulates myotube hypertrophy through the HSP72-mediated pathway in C2C12 skeletal muscle cells. Egawa T; Ohno Y; Goto A; Ikuta A; Suzuki M; Ohira T; Yokoyama S; Sugiura T; Ohira Y; Yoshioka T; Goto K Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E344-54. PubMed ID: 24347059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]